130 related articles for article (PubMed ID: 35394853)
41. Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination.
Crane P; Wong C; Mehta N; Barlis P
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34625447
[TBL] [Abstract][Full Text] [Related]
42. Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination.
Fousse M; Schub D; Merzou F; Fassbender K; Sester M; Kettner M; Lochner P; Schmidt T; Goi Júnior JR
J Neurol; 2022 Feb; 269(2):583-586. PubMed ID: 34609603
[TBL] [Abstract][Full Text] [Related]
43. Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination.
Cole A; Thomas R; Goldman N; Howell K; Chakravarty K; Denton CP; Ong VH
J Autoimmun; 2022 Apr; 128():102812. PubMed ID: 35247654
[TBL] [Abstract][Full Text] [Related]
44. A case report of ChAdOx1 nCoV-19 vaccine-associated encephalitis.
Takata J; Durkin SM; Wong S; Zandi MS; Swanton JK; Corrah TW
BMC Neurol; 2021 Dec; 21(1):485. PubMed ID: 34903200
[TBL] [Abstract][Full Text] [Related]
45. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
46. Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis.
Allen-Philbey K; Stennett A; Begum T; Johnson AC; Dobson R; Giovannoni G; Gnanapavan S; Marta M; Smets I; Turner BP; Baker D; Mathews J; Schmierer K
Mult Scler Relat Disord; 2021 Jul; 52():103028. PubMed ID: 34049216
[TBL] [Abstract][Full Text] [Related]
47. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
[No Abstract] [Full Text] [Related]
48. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.
Soltani Hekmat A; Javanmardi K
Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086
[TBL] [Abstract][Full Text] [Related]
49. Humoral immune response after different SARS-CoV-2 vaccination regimens.
Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
[TBL] [Abstract][Full Text] [Related]
50. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
[TBL] [Abstract][Full Text] [Related]
51. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA
Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606
[TBL] [Abstract][Full Text] [Related]
52. Expert review on global real-world vaccine effectiveness against SARS-CoV-2.
Chuenkitmongkol S; Solante R; Burhan E; Chariyalertsak S; Chiu NC; Do-Van D; Husin M; Hwang KP; Kiertiburanakul S; Kulkarni PS; Lee PI; Lobo RC; Nghia CH; Ong-Lim A; Sivasampu S; Suah JL; Tok PSK; Thwaites G;
Expert Rev Vaccines; 2022 Sep; 21(9):1255-1268. PubMed ID: 35748494
[TBL] [Abstract][Full Text] [Related]
53. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
[TBL] [Abstract][Full Text] [Related]
54. A narrative review of anti-SARS-CoV-2 vaccines and immune thrombocytopenia: be aware, but reassured.
Beltrami-Moreira M; Bussel JB
Clin Adv Hematol Oncol; 2022 Sep; 20(9):572-578. PubMed ID: 36125949
[TBL] [Abstract][Full Text] [Related]
55. Novel case of takotsubo cardiomyopathy following COVID-19 vaccination.
Stewart C; Gamble DT; Dawson D
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35042734
[TBL] [Abstract][Full Text] [Related]
56. Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on vaccine safety on AstraZeneca COVID-19 vaccine.
Saudi Med J; 2021 May; 42(5):581-582. PubMed ID: 33896793
[No Abstract] [Full Text] [Related]
57. [Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19].
Wolthers SA; Stenberg J; Nielsen HB; Stensballe J; Pedersen HP
Ugeskr Laeger; 2021 Aug; 183(35):. PubMed ID: 34477089
[TBL] [Abstract][Full Text] [Related]
58. Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination.
Hollstein MM; Münsterkötter L; Schön MP; Bergmann A; Husar TM; Abratis A; Eidizadeh A; Schaffrinski M; Zachmann K; Schmitz A; Holsapple JS; Stanisz-Bogeski H; Schanz J; Fischer A; Groß U; Leha A; Zautner AE; Schnelle M; Erpenbeck L
Allergy; 2022 Aug; 77(8):2381-2392. PubMed ID: 35124800
[TBL] [Abstract][Full Text] [Related]
59. Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren's syndrome.
Verstappen GM; de Wolff L; Arends S; Heiermann HM; van Sleen Y; Visser A; Terpstra JH; Diavatopoulos DA; van der Heiden M; Vissink A; van Baarle D; Kroese FGM; Bootsma H
RMD Open; 2022 Apr; 8(1):. PubMed ID: 35414631
[TBL] [Abstract][Full Text] [Related]
60. Incidence and severity of COVID-19 infection post-vaccination: a survey among Indian doctors.
Parameswaran A; Apsingi S; Eachempati KK; Dannana CS; Jagathkar G; Iyer M; Aribandi H
Infection; 2022 Aug; 50(4):889-895. PubMed ID: 35129788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
